scholarly journals A Split-Cre system designed to detect simultaneous expression of two genes based on SpyTag/SpyCatcher conjugation and Split-GFP dimerization

2021 ◽  
pp. 101119
Author(s):  
Xundong Wei ◽  
Jianhua Zhang ◽  
Jian Cui ◽  
Wei Xu ◽  
Xuyu Zhou ◽  
...  
2006 ◽  
Vol 82 (2) ◽  
pp. 193-198 ◽  
Author(s):  
Taiichi Saito ◽  
Muhamad Thohar Arifin ◽  
Seiji Hama ◽  
Yoshinori Kajiwara ◽  
Kazuhiko Sugiyama ◽  
...  

2012 ◽  
Vol 17 (1) ◽  
pp. 10 ◽  
Author(s):  
Matthias C Schauer ◽  
Nikolas H Stoecklein ◽  
Joerg Theisen ◽  
Feride Kröpil ◽  
Stephan Baldus ◽  
...  

Gene ◽  
1996 ◽  
Vol 171 (2) ◽  
pp. 209-213 ◽  
Author(s):  
Udayan Chatterji ◽  
Raies Ahmad ◽  
B. Venkaiah ◽  
Seyed E. Hasnain

Blood ◽  
1993 ◽  
Vol 82 (4) ◽  
pp. 1257-1263 ◽  
Author(s):  
D Lu ◽  
J Liu ◽  
M Campbell ◽  
JQ Guo ◽  
N Heisterkamp ◽  
...  

Abstract It is well established that the chimeric BCR-ABL gene formed by joining parts of the BCR and ABL genes plays a key role in the pathogenesis of Philadelphia (Ph) chromosome-positive leukemias. We report that simultaneous expression of P210 BCR-ABL and P160 BCR in simian COS-1 cells yielded stable complexes of these two proteins, and induced phosphorylation of P160 BCR on tyrosine residues in vivo. Tyrosine phosphorylation of a deletion mutant encoding 553 amino acids of BCR N- terminal sequences was also detected when it was coexpressed with P210 BCR-ABL. We propose that tyrosine phosphorylation of P160 BCR by P210 BCR-ABL and their stable physical interaction may perturb normal BCR functions and that these alterations are directly involved in the pathologic processes found in Ph chromosome-associated leukemias.


BioTechniques ◽  
2004 ◽  
Vol 36 (3) ◽  
pp. 382-388
Author(s):  
Oleg A. Barski ◽  
Fernando Siller-Lopez ◽  
Kurt M. Bohren ◽  
Kenneth H. Gabbay ◽  
Estuardo Aguilar-Cordova

Blood ◽  
1994 ◽  
Vol 84 (10) ◽  
pp. 3465-3472 ◽  
Author(s):  
PS Cohen ◽  
JP Chan ◽  
M Lipkunskaya ◽  
JL Biedler ◽  
RC Seeger

Abstract During development, mice with mutations of stem cell factor (SCF) or its receptor c-kit exhibit defects in melanogenesis, as well as hematopoiesis and gonadogenesis. Because melanocytes derive from neural crest cells, the role of SCF and c-kit was investigated in the neural crest-derived childhood tumor neuroblastoma. Using reverse transcription-polymerase chain reaction analysis, simultaneous expression of steady-state mRNA for the SCF ligand and its receptor c- kit was found in 14 of 14 (100%) human neuroblastoma cell lines and clones and in 8 of 18 (45%) human neuroblastoma tumor samples. Functional blockade of c-kit receptors in the cell lines SK-N-BE(2) and SH-SY5Y using the mouse monoclonal anti-c-kit antibody SR-1 resulted in a significant decrease in cellular growth rate when measured by either 3H-thymidine incorporation or clonogenicity. In addition, higher levels of c-kit mRNA expression were associated with parental neuroblastoma cell lines and subclones with a neuronal (N) differentiation phenotype, whereas lower levels of c-kit mRNA were associated with neuroblastoma cell line subclones having a schwannian/glial/melanocytic pattern of differentiation. However, the differentiation phenotype of neuroblastoma cell lines was not directly altered when c-kit expression was blocked using the SR-1 antibody. In summary, these data indicate that c-kit receptor expression may play a significant role in the growth regulation of the two neuroblastoma cell lines examined and suggest that c-kit may also play a similar role in neuroblastoma growth regulation in vivo. Simultaneous expression of SCF and c-kit mRNA in both neuroblastoma cell lines and tumors implies that c-kit may act as part of an autocrine growth loop in conjunction with endogenous production of SCF in this disease.


1991 ◽  
Vol 78 (1) ◽  
pp. 14-18 ◽  
Author(s):  
Edo Vellenga ◽  
Bernard van der Vinne ◽  
Joost Th. M. de Wolf ◽  
M. Ruud Halie

Sign in / Sign up

Export Citation Format

Share Document